-
Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk of preeclampsia.
Khalil A, Maiz N, Garcia-Mandujano R, ElKhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:402-10. pdf -
Maternal and foetal angiogenic imbalance in congenital heart defects.
Llurba E, Sánchez O, Ferrer Q, Nicolaides KH, Ruíz A, Domínguez C, Sánchez-de-Toledo J, García-García B, Soro G, Arévalo S, Goya M, Suy A, Pérez-Hoyos S, Alijotas-Reig J, Carreras E, Cabero L.
Eur Heart J 2014;35:701-7. -
Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.
Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH.
Fetal Diagn Ther 2013;33:149-55. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Maternal serum adiponectin at 11-13 weeks of gestation in predicition of macrosomia.
Nanda S, Akolekar R, Sarquis R, Mosconi AP, Nicolaides KH.
Prenat Diagn 2011;31:479-83. -
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks.
Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH.
Prenat Diagn 2011;31:135-41. -
Maternal serum adiponectin at 11-13 weeks of gestation in pregnancies delivering small for gestation neonates.
Nanda S, Akolekar R, Sodre D, Vaikousi E, Nicolaides KH.
Fetal Diagn Ther 2011;29:274-9. -
Maternal serum adiponectin at 11-13 weeks of gestation in preeclampsia.
Nanda S, Yu CK, Giurcaneanu L, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;29:208-15. -
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.
Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH.
Prenat Diagn 2011;31:66-74. -
Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
Foidart JM, Munaut C, Chantraine F, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;35:680-7. -
Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
Akolekar R, Cruz JJ, Foidart JM, Munaut C, Nicolaides KH.
Prenat Diagn 2010;30:191-7. -
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:871-6. -
Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD, Sotiriadis A, Kaihura C, Nicolaides KH, Sattar N.
Clin Sci (Lond) 2008;115:219-24. -
Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy.
Makrydimas G, Sotiriadis A, Savvidou MD, Spencer K, Nicolaides KH.
Prenat Diagn 2008;28:175-9. -
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73. -
Coelomic fluid leptin concentration in normal first-trimester pregnancies and missed miscarriages.
Makrydimas G, Vandecruys H, Sotiriadis A, Lakasing L, Spencer K, Nicolaides KH.
Fetal Diagn Ther 2005;20:406-9. -
The relationship between leptin concentration and bone metabolism in the human fetus.
Ogueh O, Sooranna S, Nicolaides KH, Johnson MR.
J Clin Endocrinol Metab 2000;85:1997-9.